Among them, AKR1C1 and AKR1C3 have been reported to be upregulated in human tumors and identified as prognostic markers for various forms of cancer, including breast, colon, bladder, and prostate cancers [22,23,24]. Here, AKR1C1 is linked to Familial prostate cancer.